Literature DB >> 30525334

Age-related deficits in intracortical myelination in young adults with bipolar disorder type I

Manpreet Sehmbi1, Christopher D. Rowley1, Luciano Minuzzi1, Flavio Kapczinski1, Jacek M. Kwiecien1, Nicholas A. Bock1, Benicio N. Frey1.   

Abstract

Background: Previous studies have implicated white-matter-related changes in the pathophysiology of bipolar disorder. However, most of what is known is derived from in vivo subcortical white-matter imaging or postmortem studies. In this study, we investigated whole-brain intracortical myelin (ICM) content in people with bipolar disorder type I and controls.
Methods: Between Sept. 1, 2014, and Jan. 31, 2017, we used a 3 T General Electric scanner to collect T1-weighted images in 45 people with bipolar disorder type I and 60 controls aged 17 to 45 years using an optimized sequence that was sensitive to ICM content. We analyzed images using a surfacebased approach. We used general linear models with quadratic age terms to examine the signal trajectory of ICM across the age range.
Results: In healthy controls, the T1-weighted signal followed an inverted-U trajectory over age; in people with bipolar disorder type I, the association between ICM and age followed a flat trajectory (p < 0.05, Bonferroni corrected). Exploratory analyses showed that ICM signal intensity was associated with duration of illness, age of onset, and anticonvulsant and antipsychotic use in people with bipolar disorder type I (p < 0.05, uncorrected). Limitations: Because of the cross-sectional nature of the study, we were unable to comment on whether the effects were due to dysmyelination or demyelination in bipolar disorder.
Conclusion: This foundational study is, to our knowledge, the first to show global age-related deficits in ICM maturation throughout the cortex in bipolar disorder. Considering the impact of myelination on the maintenance of neural synchrony and the integrity of neural connections, this work may help us better understand the cognitive and behavioural deficits seen in bipolar disorder.
© 2019 Joule Inc. or its licensors

Entities:  

Mesh:

Year:  2019        PMID: 30525334      PMCID: PMC6397039          DOI: 10.1503/jpn.170220

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  56 in total

1.  White matter hyperintensities and their association with suicidality in major affective disorders: a meta-analysis of magnetic resonance imaging studies.

Authors:  Maria Conceição Grangeon; Camila Seixas; Lucas C Quarantini; Angela Miranda-Scippa; Maurizio Pompili; David C Steffens; Amy Wenzel; Acioly L T Lacerda; Irismar Reis de Oliveira
Journal:  CNS Spectr       Date:  2010-06       Impact factor: 3.790

2.  Myelin vs axon abnormalities in white matter in bipolar disorder.

Authors:  Kathryn E Lewandowski; Dost Ongür; Sarah H Sperry; Bruce M Cohen; Selma Sehovic; Jacqueline R Goldbach; Fei Du
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 3.  The definition and meaning of treatment-resistant depression.

Authors:  H A Sackeim
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

4.  Subgenual prefrontal cortex abnormalities in mood disorders.

Authors:  W C Drevets; J L Price; J R Simpson; R D Todd; T Reich; M Vannier; M E Raichle
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

5.  Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load.

Authors:  Stefanie Hassel; Jorge Rc Almeida; Natalie Kerr; Sharon Nau; Cecile D Ladouceur; Kate Fissell; David J Kupfer; Mary L Phillips
Journal:  Bipolar Disord       Date:  2008-12       Impact factor: 6.744

6.  A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder.

Authors:  Michael P Caligiuri; Gregory G Brown; M J Meloy; Lisa T Eyler; Sandra S Kindermann; Sonja Eberson; Lawrence R Frank; James B Lohr
Journal:  Bipolar Disord       Date:  2004-06       Impact factor: 6.744

Review 7.  Dose response and dose equivalence of antipsychotics.

Authors:  John M Davis; Nancy Chen
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

8.  Glial reduction in the subgenual prefrontal cortex in mood disorders.

Authors:  D Ongür; W C Drevets; J L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 9.  Why do many psychiatric disorders emerge during adolescence?

Authors:  Tomás Paus; Matcheri Keshavan; Jay N Giedd
Journal:  Nat Rev Neurosci       Date:  2008-11-12       Impact factor: 34.870

10.  Progressive gray matter loss in patients with bipolar disorder.

Authors:  T William J Moorhead; James McKirdy; Jessika E D Sussmann; Jeremy Hall; Stephen M Lawrie; Eve C Johnstone; Andrew M McIntosh
Journal:  Biol Psychiatry       Date:  2007-07-09       Impact factor: 13.382

View more
  4 in total

1.  Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein.

Authors:  Daria A Kamaeva; Liudmila P Smirnova; Svetlana N Vasilieva; Daria V Kazantseva; Alisa R Vasilieva; Svetlana A Ivanova
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

2.  Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life.

Authors:  Jiajia Bao; Mengmeng Ma; Shuju Dong; Lijie Gao; Changling Li; Chaohua Cui; Ning Chen; Yang Zhang; Li He
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

3.  Transmembrane protein 108 inhibits the proliferation and myelination of oligodendrocyte lineage cells in the corpus callosum.

Authors:  Yongqiang Wu; Yanzi Zhong; Xufeng Liao; Xiangguang Miao; Jianbo Yu; Xinsheng Lai; Yu Zhang; Chaolin Ma; Haili Pan; Shunqi Wang
Journal:  Mol Brain       Date:  2022-04-11       Impact factor: 4.041

4.  Intracortical myelin in individuals with alcohol use disorder: An initial proof-of-concept study.

Authors:  Vanessa Morris; Nicholas Bock; Luciano Minuzzi; James MacKillop; Michael Amlung
Journal:  Brain Behav       Date:  2022-09-14       Impact factor: 3.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.